FUQA:LSE:LSE-Fidelity US Quality Income ETF Acc (GBX)

ETF | Others |

Last Closing

USD 1030.25

Change

+0.25 (+0.02)%

Market Cap

N/A

Volume

8.93K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-05 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

-3.50 (-1.50%)

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

+2.28 (+1.89%)

USD 618.20B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.17 (+0.95%)

USD 588.35B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

+0.08 (+0.58%)

USD 588.35B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

+0.40 (+0.64%)

USD 266.08B
0QZO:LSE 0QZO

-1.00 (-0.88%)

USD 258.54B
PRJU:LSE Amundi Index Solutions - Amund..

+0.24 (+0.80%)

USD 244.75B
0QZ3:LSE Qualcomm Inc.

+0.93 (+0.54%)

USD 202.26B
0R24:LSE Intel Corp.

N/A

USD 196.14B

ETFs Containing FUQA:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.76% 25% F 34% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.76% 23% F 34% F
Trailing 12 Months  
Capital Gain 16.91% 71% C- 70% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 16.91% 70% C- 68% D+
Trailing 5 Years  
Capital Gain 77.32% 84% B 86% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 77.32% 83% B 85% B
Average Annual (5 Year Horizon)  
Capital Gain 15.19% 78% C+ 78% C+
Dividend Return 15.19% 78% C+ 77% C+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 9.18% 72% C 84% B
Risk Adjusted Return 165.55% 100% F 100% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike